New Immunomodulatory Therapy Strategies in Chronic Reactive Arthritis

NCT00244179 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Reactive Arthritis

Interventions

DRUG: interferon-gamma
DRUG: infliximab
DRUG: dmard

Sponsor

Charite University, Berlin, Germany

Collaborators

[object Object]